Company intelligence / Profile preview

Hassman Research Institute

Berlin, New Jersey, United States

Ownership: Private
Employees: ~101
Development stage: Other

Overview

Hassman Research Institute (now CenExel HRI) conducts both inpatient and outpatient Phase I-IV clinical trials focused on central nervous system (CNS) disorders, vaccines, analgesia/pain, and other medical indications, consistently meeting and exceeding patient recruitment and quality standards[2][3][4].

Therapeutic areas: OphthalmologyEndocrinologyPulmonologyInfectious DiseasesNeurologyWomen's HealthOtherDermatologyPsychiatry
Industry: Contract Research Organization

Partnerships

CenExelApex Innovative Sciences (following merger)

Beyond the preview

Go deeper on Hassman Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hassman Research Institute.

Explore the full profile